FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

20532811000001109: Neisseria meningitidis group W135 capsular polysaccharide protein conjugate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69119001000001119 Neisseria meningitidis group W135 capsular polysaccharide protein conjugate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69119101000001118 Neisseria meningitidis group W135 capsular polysaccharide protein conjugate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Is a Antigen of Neisseria meningitidis true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
ACWY Vax powder and solvent for solution for injection 0.5ml vials (GlaxoSmithKline) 1 vial Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
ACWY Vax powder and solvent for solution for injection 0.5ml vials (GlaxoSmithKline) Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials 1 vial Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine solution for injection 0.5ml vials Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine solution for injection 0.5ml vials 1 vial Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
MenQuadfi vaccine solution for injection 0.5ml vials (Sanofi Pasteur) 1 vial Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
MenQuadfi vaccine solution for injection 0.5ml vials (Sanofi Pasteur) Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Nimenrix vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd) Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal polysaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier
Nimenrix vaccine powder and solvent for solution for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Neisseria meningitidis group W135 capsular polysaccharide protein conjugate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start